TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32005202

Group type: EXPERIMENTAL
Intervention: Community health worker recruitment (door-to-door)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Community health meetings
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Integrated package of cervical cancer screening and education
Number of subjects: 31
Study: 35461689

Group type: EXPERIMENTAL
Intervention: MI3 algorithm (machine learning algorithm)
Number of subjects: 20761
Study: 35166608

Group type: EXPERIMENTAL
Intervention: Physiotherapy treatment plus virtual reality exercises with the Nintendo Wii console (n=36)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Physiotherapy treatment (control group, n=37)
Number of subjects: 73
Study: 33588078

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (2000 IU daily)
Number of subjects: 666

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 666
Study: 32639634

Group type: EXPERIMENTAL
Intervention: High dose (10 mg/kg daily)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Low dose (5 mg/kg daily)
Number of subjects: 111
Study: 36303303

Group type: EXPERIMENTAL
Intervention: Tailored reproductive health promotion programme based on the Precaution Adoption Process Model (PAPM) over 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Educational material
Number of subjects: 60
Study: 32981056

Group type: EXPERIMENTAL
Intervention: Loading dose of 0.5 mg/kg ketamine followed by continuous infusion of 5 μg/kg/min (K1 group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Loading dose of 0.5 mg/kg ketamine followed by continuous infusion of 10 μg/kg/min (K2 group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Loading dose of 0.5 mg/kg ketamine followed by continuous infusion of 20 μg/kg/min (K3 group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sevoflurane alone (K0 group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: K2 and K3 groups compared to K1 group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: K3 group compared to K2 group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: K2 and K3 groups compared to K0 and K1 groups
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Heart rate and MAP after pneumoperitoneum
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Overall haemodynamics during the study period
Number of subjects: 100
Study: 32513228

Group type: EXPERIMENTAL
Intervention: Non-surgical treatment
Number of subjects: 422
Study: 35591748

Group type: EXPERIMENTAL
Intervention: Educational SMS ± additional support group (ESMS±S)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Simple SMS group
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 196
Study: 32891521

Group type: EXPERIMENTAL
Intervention: In-plane ultrasound guidance
Number of subjects: 84

Group type: COMPARATOR
Intervention: Out-of-plane ultrasound guidance
Number of subjects: 84
Study: 32453346

Group type: EXPERIMENTAL
Intervention: Workplace wellness program with financial incentives and paid time off for biometric screenings and health risk assessments.
Number of subjects: 4834

Group type: EXPERIMENTAL
Intervention: Workplace wellness program
Number of subjects: 4834

Group type: COMPARATOR
Intervention: Control group (no participation in wellness program)
Number of subjects: 4834
Study: 35007748

Group type: EXPERIMENTAL
Intervention: Crimson duvet procedure (CDP) with microfracture treatment of the footprint
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group with débridement of the footprint
Number of subjects: 123
Study: 33243143

Group type: EXPERIMENTAL
Intervention: Bacillus thuringiensis strains (tenebrionis 4AA1 carrying pBMB76 and kurstaki HD73 carrying pHT73)
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: Mixed application of Bacillus thuringiensis strains (4AA1 + HD73)
Number of subjects: 684
Study: 35090154

Group type: EXPERIMENTAL
Intervention: Suppressive valacyclovir treatment for 1 year
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 400
Study: 33749386

Group type: EXPERIMENTAL
Intervention: Hypothetical interventions targeting multiple mediators (not specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: G-computation method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-harm example from the Victorian Adolescent Health Cohort Study
Number of subjects: 0
Study: 32814593

Group type: EXPERIMENTAL
Intervention: Holographic (HG) anatomic model
Number of subjects: 29

Group type: COMPARATOR
Intervention: Didactic lecture (DL)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Computer module (CM)
Number of subjects: 29
Study: 32831210

Group type: EXPERIMENTAL
Intervention: Virtual Reality Training (VRT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Isokinetic Training (IKT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control Group (NCONTROL)
Number of subjects: 60
Study: 33753652

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gel combined with calcium hydroxide (CH + CHX) for 1 week
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gel combined with calcium hydroxide (CH + CHX) for 2 weeks
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gel combined with calcium hydroxide (CH + CHX) for 3 weeks
Number of subjects: 90
Study: 36396065

Group type: EXPERIMENTAL
Intervention: Gamified weight loss program
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Inhibitory Control Training (ICT)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Gamified weight loss program + ICT
Number of subjects: 228

Group type: COMPARATOR
Intervention: Non-gamified weight loss program + Sham ICT
Number of subjects: 228
Study: 33629100

Group type: EXPERIMENTAL
Intervention: Roxadustat
Number of subjects: 1043

Group type: COMPARATOR
Intervention: Epoetin alfa
Number of subjects: 1043
Study: 32726105

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion
Number of subjects: 1614

Group type: COMPARATOR
Intervention: Vehicle lotion
Number of subjects: 1614
Study: 35568193

Group type: EXPERIMENTAL
Intervention: Atrial sensing ON
Number of subjects: 640

Group type: COMPARATOR
Intervention: Atrial sensing OFF
Number of subjects: 640
Study: 34689745

Group type: EXPERIMENTAL
Intervention: Standardized birthing room intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 33095032

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 3730
Study: 35759365

Group type: EXPERIMENTAL
Intervention: Teens Taking Charge Cancer web-based self-management program
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (education with links to 12 general cancer websites)
Number of subjects: 81
Study: 34769960

Group type: EXPERIMENTAL
Intervention: Continuous therapeutic ultrasound (CUS; at 0.4 W/cm2)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pulsed therapeutic ultrasound (PUS; at 20% duty cycle, 0.08 W/cm2)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (equipment on, no energy provided)
Number of subjects: 10
Study: 36330051

Group type: EXPERIMENTAL
Intervention: Methylene Blue (MB) injection
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control (standard pathological work-up)
Number of subjects: 162
Study: 34534517

Group type: EXPERIMENTAL
Intervention: Voluntary daily lateral flow device (LFD) testing for 7 days with LFD-negative contacts remaining at school
Number of subjects: 201

Group type: COMPARATOR
Intervention: Self-isolation of school-based COVID-19 contacts for 10 days
Number of subjects: 201
Study: 32270638

Group type: EXPERIMENTAL
Intervention: Pelvic‐sacral tendon‐regulation needling technique of acupuncture combined with manipulative reduction
Number of subjects: 80

Group type: COMPARATOR
Intervention: Simple manipulative therapy
Number of subjects: 80
Study: 36148467

Group type: EXPERIMENTAL
Intervention: Avidekel oil (30% cannabidiol and 1% tetrahydrocannabinol: 295 mg and 12.5 mg per ml)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo oil
Number of subjects: 60
Study: 32756556

Group type: EXPERIMENTAL
Intervention: SRL
Number of subjects: 71

Group type: COMPARATOR
Intervention: CsA
Number of subjects: 71
Study: 32224728

Group type: EXPERIMENTAL
Intervention: Video assessment tool for 2-stage esophagectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Photographic assessment tool for 2-stage esophagectomy
Number of subjects: 0
Study: 34243808

Group type: EXPERIMENTAL
Intervention: Self-administered mirror therapy (MT) education in addition to regular rehabilitation interventions for 4 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Regular rehabilitation interventions
Number of subjects: 36
Study: 35380419

Group type: EXPERIMENTAL
Intervention: Ferric pyrophosphate citrate (FPC) administered as a single intravenous dose of 6.5 mg to healthy subjects.
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ferric pyrophosphate citrate (FPC) administered at two sequential hemodialysis treatments: HD dose 1 (27.2 mg at 95 μg/L for 4 h) and HD dose 2 (6.5 mg via pre-dialyzer blood circuit).
Number of subjects: 26

Group type: COMPARATOR
Intervention: Comparison of PK parameters between HD dose 1 and HD dose 2.
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Safety profile of FPC in both groups.
Number of subjects: 26
Study: 34196445

Group type: EXPERIMENTAL
Intervention: Personalized depression risk information
Number of subjects: 712

Group type: COMPARATOR
Intervention: Control group (no personalized risk information)
Number of subjects: 712
Study: 32560739

Group type: EXPERIMENTAL
Intervention: 15 g of active ZHWFG three times daily
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: 10 g of active ZHWFG plus 5 g of ZHWFG‐matched placebo three times daily
Number of subjects: 216

Group type: COMPARATOR
Intervention: 15 g of ZHWFG‐matched placebo three times daily
Number of subjects: 216
Study: 35409525

Group type: EXPERIMENTAL
Intervention: 2-day stress management training program and another half‐day booster after four and six months
Number of subjects: 174

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 174
Study: 33975149

Group type: EXPERIMENTAL
Intervention: Two nights of sleep disruption
Number of subjects: 79

Group type: COMPARATOR
Intervention: Two nights of uninterrupted sleep
Number of subjects: 79
Study: 34406911

Group type: EXPERIMENTAL
Intervention: Adjuvanted recombinant zoster vaccine (RZV)
Number of subjects: 1846

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1846
Study: 32444133

Group type: EXPERIMENTAL
Intervention: Eswab scraping with Amies transport medium
Number of subjects: 40

Group type: COMPARATOR
Intervention: 23‐gauge needle scraping in BACTEC Peds broth
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combined methods
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Needle scraping first
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Eswab method
Number of subjects: 40
Study: 33771081

Group type: EXPERIMENTAL
Intervention: Prophylactic caffeine
Number of subjects: 181

Group type: COMPARATOR
Intervention: Therapeutic caffeine
Number of subjects: 181
Study: 33876784

Group type: EXPERIMENTAL
Intervention: Epidural blockade with 0, 50, 100 or 150 mg of epidural ropivacaine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Propofol at concentrations up to 6 μg ml-1
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Combination of epidural anaesthesia and intravenous propofol
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Epidural blockade
Number of subjects: 28
Study: 33586626

Group type: EXPERIMENTAL
Intervention: Initial Aqualizer™ therapy (Group 1)
Number of subjects: 53

Group type: COMPARATOR
Intervention: No initial therapy (Group 2)
Number of subjects: 53
Study: 35560319

Group type: EXPERIMENTAL
Intervention: Coca Cola (blind condition)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Cola beverage (blind condition)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Coca Cola (not blind condition)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Cola beverage (not blind condition)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Brand knowledge (not blind condition)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Preference change from blind to not blind conditions
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Physiological response (blind vs not blind)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Consumer vs non-consumer of Coca-Cola
Number of subjects: 25
Study: 34517140

Group type: EXPERIMENTAL
Intervention: Normoxemia (FIO2 titrated to oxygen saturation of 95-98%)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Hyperoxia (FIO2 = 0.8)
Number of subjects: 106
Study: 33872554

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 0
Study: 32448382

Group type: EXPERIMENTAL
Intervention: Thrice daily Biphasic Human Insulin 30 (BHI 30)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Twice daily Biphasic Human Insulin 30 (BHI 30)
Number of subjects: 22
Study: 35705982

Group type: EXPERIMENTAL
Intervention: Virtual Reality technology
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (traditional teaching methods)
Number of subjects: 50
Study: 33065208

Group type: EXPERIMENTAL
Intervention: Yoga (n = 30)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Support group (n = 18)
Number of subjects: 48
Study: 35430718

Group type: EXPERIMENTAL
Intervention: Aerosolized capsaicin (AC), 1-10 drops of liquid cayenne extract (1.5-2% capsaicin) in 100 mL carbonated water.
Number of subjects: 60
Study: 33275318

Group type: EXPERIMENTAL
Intervention: Imeglimin 500 mg
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Imeglimin 1000 mg
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Imeglimin 1500 mg
Number of subjects: 299

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study: 32400903

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT) adapted for SE-AN
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced cognitive behavioral therapy (CBT-E)
Number of subjects: 0
Study: 35940478

Group type: EXPERIMENTAL
Intervention: Physiotherapy + gastrocnemius vibration (FV_GM)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Physiotherapy + tibialis anterior vibration (FV_TA)
Number of subjects: 64
Study: 33571026

Group type: EXPERIMENTAL
Intervention: Ginkgolide plus aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus aspirin
Number of subjects: 0
Study: 32988524

Group type: COMPARATOR
Intervention: Basal diet (2,000 IU vitamin D3)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Diet supplemented with 3 ppm Cx and 34.5 μg 25-OH-D3
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Diet supplemented with 6 ppm Cx and 69 μg 25-OH-D3
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Diet supplemented with 9 ppm Cx and 103.5 μg 25-OH-D3
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Diet supplemented with 12 ppm Cx and 138 μg 25-OH-D3
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Diet supplemented with varying levels of Cx and 25-OH-D3
Number of subjects: 240
Study: 35830338

Group type: EXPERIMENTAL
Intervention: Low-Intensity Shock Wave Therapy (LiST)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 70
Study: 33546941

Group type: EXPERIMENTAL
Intervention: Sucralose
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Stevia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sucrose
Number of subjects: 20
Study: 32085823

Group type: EXPERIMENTAL
Intervention: ART plus vorinostat and T-cell inducing vaccines (ART + V + V)
Number of subjects: 60

Group type: COMPARATOR
Intervention: ART-only
Number of subjects: 60
Study: 33006288

Group type: EXPERIMENTAL
Intervention: VIA-IS
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (goal-setting as usual)
Number of subjects: 26
Study: 34178828

Group type: EXPERIMENTAL
Intervention: Drinking 1 liter of water per day before each main meal (PW group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No water consumption before any meal (NPW group)
Number of subjects: 40
Study: 35194169

Group type: COMPARATOR
Intervention: Cervical collars (c-collars)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Folded towels
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Foam neck braces
Number of subjects: 30
Study: 32475440

Group type: EXPERIMENTAL
Intervention: 1 g C. lanatus essential oil/kg feed (1gCL)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 2 g C. lanatus essential oil/kg feed (2gCL)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: C. lanatus essential oils in diets
Number of subjects: 72
Study: 34477812

Group type: EXPERIMENTAL
Intervention: MCI Gel
Number of subjects: 25

Group type: COMPARATOR
Intervention: Cheese
Number of subjects: 25

Group type: COMPARATOR
Intervention: Hom. Cheese
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: MCI Drink
Number of subjects: 25
Study: 34716530

Group type: EXPERIMENTAL
Intervention: Weighted rank test for comparing marginal survival distributions between intervention arms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sample size calculation method
Number of subjects: 0
Study: 33313858

Group type: EXPERIMENTAL
Intervention: Mobile phone-based support in addition to usual care
Number of subjects: 75

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 75
Study: 34068089

Group type: EXPERIMENTAL
Intervention: 1-set Resistance Training (1-RT)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 3-set Resistance Training (3-RT)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Whole Body Electromyostimulation (WB-EMS)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Inactive Control Group (CON)
Number of subjects: 118
Study: 32654897

Group type: EXPERIMENTAL
Intervention: Bariatric surgery (gastric bypass, vertical banded gastroplasty, gastric banding)
Number of subjects: 3597

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 3597

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 3597
Study: 35322637

Group type: EXPERIMENTAL
Intervention: Individualized treatment (basic treatment, Qiming granules, individualized Chinese herbal medicines)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Stationary treatment (basic treatment and Qiming granules)
Number of subjects: 140
Study: 32880495

Group type: EXPERIMENTAL
Intervention: Selumetinib (75 mg twice a day) in combination with docetaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selumetinib (monotherapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selumetinib (in combination with docetaxel)
Number of subjects: 0
Study: 33610365

Group type: EXPERIMENTAL
Intervention: Optimal medical therapy (combination of 4 drugs: ACE inhibitor or ARB, beta-blocker, statin, and 1 antiplatelet drug)
Number of subjects: 1212

Group type: EXPERIMENTAL
Intervention: Optimal medical therapy
Number of subjects: 1212

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting with medical therapy
Number of subjects: 1212

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 1212
Study: 33514272

Group type: COMPARATOR
Intervention: Egocentric task (free-trunk condition)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Egocentric task (blocked-trunk condition)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exocentric task (free-trunk condition)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exocentric task (blocked-trunk condition)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exocentric movement after stroke
Number of subjects: 0
Study: 36350714

Group type: EXPERIMENTAL
Intervention: Bimonthly cash transfers and nutrition education
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Bimonthly cash transfers alone
Number of subjects: 599

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 599
Study: 32030023

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 48

Group type: COMPARATOR
Intervention: Care as Usual
Number of subjects: 48
Study: 35935311

Group type: EXPERIMENTAL
Intervention: Logistic Regression (LR) classifier
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Linear Discriminant (LD) classifier
Number of subjects: 150

Group type: COMPARATOR
Intervention: Group B1 (metastasis within 0.5 years)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Group B2 (metastasis within 0.5-1.0 years)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Group B3 (metastasis within 1.0-2.0 years)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Texture features of CT images based on AI algorithms
Number of subjects: 150
Study: 34432302

Group type: EXPERIMENTAL
Intervention: PAS-calcium formulation (PAS-Ca)
Number of subjects: 0
Study: 34402789

Group type: EXPERIMENTAL
Intervention: Chemi Enoxaparin (80 mg/0.8 mL)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Clexane (80 mg/0.8 mL)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both compounds
Number of subjects: 47
Study: 33256420

Group type: EXPERIMENTAL
Intervention: Endoscopic tattooing with two injection points and 1 ml of labeling volume
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Endoscopic tattooing with three injection points and 1.5 ml of labeling volume
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Endoscopic tattooing with two injection points and 1.5 ml of labeling volume
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Endoscopic tattooing with three injection points and 1 ml of labeling volume
Number of subjects: 195
Study: 32230754

Group type: EXPERIMENTAL
Intervention: Extra virgin olive oil (EVOO), 50 mL daily for 3 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Refined olive oil (ROO), 50 mL daily for 3 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison between EVOO and ROO
Number of subjects: 30
Study: 35899379

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Health enhancement program (HEP)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Long-term meditators
Number of subjects: 115
Study: 34131924

Group type: EXPERIMENTAL
Intervention: AOG‐3DP (3D printed access opening guide)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (no aid)
Number of subjects: 90